Works matching DE "ANTIBODY-toxin conjugates"
Results: 448
Attempts to Express the Al-GMCSF Immunotoxin in the Baculovirus Expression Vector System.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2012, v. 76, n. 4, p. 749, doi. 10.1271/bbb.110862
- By:
- Publication type:
- Article
Cover Feature: <sup>64</sup>Cu tumor labeling with hexadentate picolinic acid‐based bispidine immunoconjugates (Chem. Eur. J. 32/2024).
- Published in:
- Chemistry - A European Journal, 2024, v. 30, n. 32, p. 1, doi. 10.1002/chem.202401745
- By:
- Publication type:
- Article
<sup>64</sup>Cu tumor labeling with hexadentate picolinic acid‐based bispidine immunoconjugates.
- Published in:
- Chemistry - A European Journal, 2024, v. 30, n. 32, p. 1, doi. 10.1002/chem.202400366
- By:
- Publication type:
- Article
Transferrin Receptor-Mediated Endocytosis: A Useful Target for Cancer Therapy.
- Published in:
- Journal of Membrane Biology, 2014, v. 247, n. 4, p. 291, doi. 10.1007/s00232-014-9637-0
- By:
- Publication type:
- Article
Selective lesion of medial septal cholinergic neurons followed by a mini-stroke impairs spatial learning in rats.
- Published in:
- Experimental Brain Research, 2009, v. 193, n. 1, p. 29, doi. 10.1007/s00221-008-1592-5
- By:
- Publication type:
- Article
Construction and characterization of an anti-asialoglycoprotein receptor single-chain variable-fragment-targeted melittin.
- Published in:
- Biotechnology & Applied Biochemistry, 2011, v. 58, n. 6, p. 405, doi. 10.1002/bab.57
- By:
- Publication type:
- Article
Randomized Trial of [131I] Metuximab in Treatment of Hepatocellular Carcinoma After Percutaneous Radiofrequency Ablation.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 9, p. 1, doi. 10.1093/jnci/dju239
- By:
- Publication type:
- Article
EphA2 Immunoconjugate as Molecularly Targeted Chemotherapy for Ovarian Carcinoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 17, p. 1193, doi. 10.1093/jnci/djp231
- By:
- Publication type:
- Article
Whatever Happened to Immunotoxins? Research, and Hope, Are Still Alive.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 9, p. 624, doi. 10.1093/jnci/djp110
- By:
- Publication type:
- Article
Dual fluorescent N-(2-hydroxypropyl) methacrylamide-based conjugates for passive tumor targeting with reduction-sensitive drug release: Proof of the concept, tumor accumulation, and biodistribution.
- Published in:
- Journal of Bioactive & Compatible Polymers, 2016, v. 31, n. 4, p. 348, doi. 10.1177/0883911515618975
- By:
- Publication type:
- Article
In vitro and preclinical targeted alpha therapy of human prostate cancer with Bi-213 labeled J591 antibody against the prostate specific membrane antigen.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2002, v. 5, n. 1, p. 36, doi. 10.1038/sj.pcan.4500543
- By:
- Publication type:
- Article
Xenotransplantation literature update, July-October 2011.
- Published in:
- Xenotransplantation, 2011, v. 18, n. 6, p. 400, doi. 10.1111/j.1399-3089.2011.00682.x
- By:
- Publication type:
- Article
Nanobody-Based EGFR-Targeting Immunotoxins for Colorectal Cancer Treatment.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 7, p. 1042, doi. 10.3390/biom13071042
- By:
- Publication type:
- Article
Immunotoxins: From Design to Clinical Application.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 11, p. 1696, doi. 10.3390/biom11111696
- By:
- Publication type:
- Article
Anti-BCMA Immunotoxins: Design, Production, and Preclinical Evaluation.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 10, p. 1387, doi. 10.3390/biom10101387
- By:
- Publication type:
- Article
Development of Recombinant Immunotoxins for Hairy Cell Leukemia.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 8, p. 1140, doi. 10.3390/biom10081140
- By:
- Publication type:
- Article
Mechanisms of Resistance to Immunotoxins Containing Pseudomonas Exotoxin A in Cancer Therapy.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 7, p. 979, doi. 10.3390/biom10070979
- By:
- Publication type:
- Article
Mesothelin-Targeted Recombinant Immunotoxins for Solid Tumors.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 7, p. 973, doi. 10.3390/biom10070973
- By:
- Publication type:
- Article
Development of Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer: An Update.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 6, p. 934, doi. 10.3390/biom10060934
- By:
- Publication type:
- Article
Targeted Diphtheria Toxin-Based Therapy: A Review Article.
- Published in:
- Frontiers in Microbiology, 2019, p. 1, doi. 10.3389/fmicb.2019.02340
- By:
- Publication type:
- Article
Effect of an immunotoxin to folate receptor β on bleomycin-induced experimental pulmonary fibrosis.
- Published in:
- Clinical & Experimental Immunology, 2010, v. 161, n. 2, p. 348, doi. 10.1111/j.1365-2249.2010.04182.x
- By:
- Publication type:
- Article
Electrochemical Immunosensing of ST2: A Checkpoint Target in Cancer Diseases.
- Published in:
- Biosensors (2079-6374), 2021, v. 11, n. 6, p. 202, doi. 10.3390/bios11060202
- By:
- Publication type:
- Article
Letting go.
- Published in:
- Nature Biotechnology, 2007, v. 25, n. 11, p. 1221, doi. 10.1038/nbt1107-1221
- Publication type:
- Article
Arming antibodies: prospects and challenges for immunoconjugates.
- Published in:
- Nature Biotechnology, 2005, v. 23, n. 9, p. 1137, doi. 10.1038/nbt1141
- By:
- Publication type:
- Article
Sequence of a symbiont.
- Published in:
- Nature Biotechnology, 2003, v. 21, n. 11, p. 1294, doi. 10.1038/nbt1103-1294
- By:
- Publication type:
- Article
Taming ricin toxin.
- Published in:
- Nature Biotechnology, 2003, v. 21, n. 4, p. 372, doi. 10.1038/nbt0403-372
- By:
- Publication type:
- Article
Macrophages and cutaneous inflammation.
- Published in:
- Nature Biotechnology, 2000, v. 18, n. 1, p. 25, doi. 10.1038/71879
- By:
- Publication type:
- Article
Resolution of cutaneous inflammation after local elimination of macrophages.
- Published in:
- Nature Biotechnology, 2000, v. 18, n. 1, p. 48, doi. 10.1038/71908
- By:
- Publication type:
- Article
Role of transglutaminase 2 in celiac disease pathogenesis.
- Published in:
- Seminars in Immunopathology, 2012, v. 34, n. 4, p. 513, doi. 10.1007/s00281-012-0305-0
- By:
- Publication type:
- Article
Independent folding and conformational changes of the barnase module in the VL-barnase immunofusion: calorimetric evidence
- Published in:
- FEBS Letters, 2004, v. 557, n. 1-3, p. 248, doi. 10.1016/S0014-5793(03)01509-6
- By:
- Publication type:
- Article
Ribosome-inactivating proteins: progress and problems.
- Published in:
- Cellular & Molecular Life Sciences, 2006, v. 63, n. 16, p. 1850, doi. 10.1007/s00018-006-6078-7
- By:
- Publication type:
- Article
Role of Striatal Cholinergic Interneurons in Set-Shifting in the Rat.
- Published in:
- Journal of Neuroscience, 2015, v. 35, n. 25, p. 9424, doi. 10.1523/JNEUROSCI.0490-15.2015
- By:
- Publication type:
- Article
Cholinergic Contributions to Supramodal Attentional Processes in Rats.
- Published in:
- Journal of Neuroscience, 2014, v. 34, n. 6, p. 2264, doi. 10.1523/JNEUROSCI.1024-13.2014
- By:
- Publication type:
- Article
Signals through the Striatopallidal Indirect Pathway Stop Movements by Phasic Excitation in the Substantia Nigra.
- Published in:
- Journal of Neuroscience, 2013, v. 33, n. 17, p. 7583, doi. 10.1523/JNEUROSCI.4932-12.2013
- By:
- Publication type:
- Article
The anti-CD20 antibody rituximab augments the immunospecific therapeutic effectiveness of an anti-CD19 immunotoxin directed against human B-cell lymphoma.
- Published in:
- British Journal of Haematology, 2006, v. 134, n. 2, p. 157, doi. 10.1111/j.1365-2141.2006.06155.x
- By:
- Publication type:
- Article
A CD33-specific single-chain immunotoxin mediates potent apoptosis of cultured human myeloid leukaemia cells.
- Published in:
- British Journal of Haematology, 2006, v. 133, n. 2, p. 141, doi. 10.1111/j.1365-2141.2005.05869.x
- By:
- Publication type:
- Article
The role of gemtuzumab ozogamicin in acute leukaemia therapy.
- Published in:
- British Journal of Haematology, 2006, v. 132, n. 4, p. 398, doi. 10.1111/j.1365-2141.2005.05872.x
- By:
- Publication type:
- Article
Gemtuzumab ozogamicin (Mylotarg) has therapeutic activity against CD33<sup>+</sup> acute lymphoblastic leukaemiasin vitroandin vivo.
- Published in:
- British Journal of Haematology, 2005, v. 128, n. 3, p. 310, doi. 10.1111/j.1365-2141.2004.05322.x
- By:
- Publication type:
- Article
In vitro anti-tumour activity of anti-CD80 and anti-CD86 immunotoxins containing type 1 ribosome-inactivating proteins.
- Published in:
- British Journal of Haematology, 2000, v. 110, n. 2, p. 351, doi. 10.1046/j.1365-2141.2000.02193.x
- By:
- Publication type:
- Article
Anti-B4-blocked ricin: a phase II trial of 7 day continuous infusion in patients with multiple myeloma.
- Published in:
- British Journal of Haematology, 1998, v. 102, n. 2, p. 509, doi. 10.1046/j.1365-2141.1998.00799.x
- By:
- Publication type:
- Article
Evaluation of immunotoxins containing single-chain ribosome-inactivating proteins and an anti-CD22 monoclonal antibody (OM124): in vitro andin vivo studies.
- Published in:
- British Journal of Haematology, 1998, v. 101, n. 1, p. 179, doi. 10.1046/j.1365-2141.1998.00665.x
- By:
- Publication type:
- Article
IMMUNOTHERAPY OF CANCER (817.1-817.27).
- Published in:
- 2005
- Publication type:
- Abstract
Live-cell super-resolution imaging with trimethoprim conjugates.
- Published in:
- Nature Methods, 2010, v. 7, n. 9, p. 717, doi. 10.1038/nmeth.1489
- By:
- Publication type:
- Article
Recombinant immunotoxins development for HER2-based targeted cancer therapies.
- Published in:
- 2021
- By:
- Publication type:
- Literature Review
A Human Recombinant Autoantibody-Based Immunotoxin Specific for the Fetal Acetylcholine Receptor Inhibits Rhabdomyosarcoma Growth In Vitro and in a Murine Transplantation Model.
- Published in:
- Journal of Biomedicine & Biotechnology, 2010, p. 1, doi. 10.1155/2010/187621
- By:
- Publication type:
- Article
Construction and Characterization of a CTLA-4-Targeted scFv–Melittin Fusion Protein as a Potential Immunosuppressive Agent for Organ Transplant.
- Published in:
- Cell Biochemistry & Biophysics, 2013, v. 67, n. 3, p. 1067, doi. 10.1007/s12013-013-9605-9
- By:
- Publication type:
- Article
Development and investigation of recombinant immunotoxin protein 4D5scFv-mCherry-PE(40).
- Published in:
- Doklady Biochemistry & Biophysics, 2016, v. 471, n. 1, p. 450, doi. 10.1134/S160767291606020X
- By:
- Publication type:
- Article
Development of a recombinant immunotoxin for the immunotherapy of autoreactive lymphocytes expressing MOG-specific BCRs.
- Published in:
- Biotechnology Letters, 2016, v. 38, n. 7, p. 1173, doi. 10.1007/s10529-016-2092-5
- By:
- Publication type:
- Article
Human mesenchymal stem cells-like cells as cellular vehicles for delivery of immunotoxin in vitro.
- Published in:
- Biotechnology Letters, 2009, v. 31, n. 2, p. 181, doi. 10.1007/s10529-008-9860-9
- By:
- Publication type:
- Article
Intricacies in the Preparation of Patient Doses of [<sup>177</sup>Lu]Lu-Rituximab and [<sup>177</sup>Lu]Lu-Trastuzumab Using Low Specific Activity [<sup>177</sup>Lu]LuCl<sub>3</sub>: Methodological Aspects.
- Published in:
- Molecular Imaging & Biology, 2024, v. 26, n. 1, p. 61, doi. 10.1007/s11307-023-01846-1
- By:
- Publication type:
- Article